title: Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
abstract: BACKGROUND
  Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for the treatment of anxiodepressive states that are often associated with perturbed circadian rhythms including, in certain patients, phase advances. Surprisingly, the influence of SSRIs upon circadian activity rhythms has been little studied in experimental models.
  
  
  OBJECTIVE
  Accordingly, this study examined the ability of SSRIs to modulate the phase-setting properties of light on circadian activity rhythms in hamsters. Their actions were compared to those of the mixed serotonin/noradrenaline reuptake inhibitor (SNRI), venlafaxine, the selective noradrenaline reuptake inhibitor, reboxetine, and the dopamine reuptake inhibitor, bupropion.
  
  
  METHODS
  Wheel-running activity rhythms were recorded in male Syrian hamsters. Drugs were administered systemically before a light stimulus that was used to advance the timing of the hamster running rhythms.
  
  
  RESULTS
  Four chemically diverse SSRIs, citalopram (1-10 mg/kg, intraperitoneally), fluvoxamine (1-10), paroxetine (1-10), and fluoxetine (10 and 20), all robustly and significantly inhibited the ability of light to phase advance hamster circadian wheel-running activity rhythms. Their actions were mimicked by venlafaxine (1-10) that likewise elicited a marked reduction in phase advances. Conversely, reboxetine (1-20) and bupropion (1-20) did not exert significant effects.
  
  
  CONCLUSIONS
  These data suggest that suppression of serotonin (but not noradrenaline or dopamine) reuptake by SSRIs and SNRIs modifies circadian locomotor activity rhythms in hamsters. Further, they support the notion that an inhibitory influence upon the early-morning light-induced advance in circadian activity contributes to the therapeutic effects of serotonin uptake inhibitors in certain depressed patients.
authors: Department of Biology, Valdosta State University, Valdosta, GA 31698, USA. rlgannon@valdosta.edu
authors: Robert L
authors: RL
authors: Gannon
authors: Mark J
authors: MJ
authors: Millan
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology*; D000818:Animals; D016642:Bupropion / Q000494:pharmacology*; D002940:Circadian Rhythm / Q000187:drug effects*; D006224:Cricetinae; D003511:Cyclohexanols / Q000494:pharmacology*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D008027:Light; D008297:Male; D008647:Mesocricetus; D009025:Morpholines / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D000077593:Reboxetine; D012420:Running; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D000069470:Venlafaxine Hydrochloride
chemical_list: D018759:Adrenergic Uptake Inhibitors; D016642:Bupropion; D003511:Cyclohexanols; D018765:Dopamine Uptake Inhibitors; D009025:Morpholines; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride
references: J Comp Neurol. 1999 May 24;408(1):73-96
references: 10331581
references: Biol Psychiatry. 2000 May 1;47(9):818-29
references: 10812041
references: J Biol Rhythms. 1998 Jun;13(3):209-18
references: 9615285
references: Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S17-20
references: 16436935
references: Pharmacol Biochem Behav. 1996 May;54(1):229-34
references: 8728562
references: Brain Res. 1993 Nov 5;627(1):41-8
references: 8293303
references: Cell Tissue Res. 1995 Apr;280(1):87-96
references: 7750139
references: Int J Neuropsychopharmacol. 2003 Jun;6(2):191-7
references: 12890312
references: Psychol Med. 2005 Apr;35(4):511-7
references: 15856721
references: Neuroscience. 2006 Sep 1;141(3):1545-52
references: 16750888
references: Pharmacol Biochem Behav. 1992 Oct;43(2):549-61
references: 1438492
references: Chronobiologia. 1983 Jul-Sep;10(3):269-79
references: 6685610
references: Int J Neuropsychopharmacol. 2004 Jun;7(2):193-218
references: 15003145
references: Brain Res. 1997 Jul 11;762(1-2):185-94
references: 9262172
references: J Neurosci. 2006 Jun 14;26(24):6406-12
references: 16775127
references: Proc Natl Acad Sci U S A. 2006 May 9;103(19):7414-9
references: 16648247
references: Curr Opin Genet Dev. 2003 Jun;13(3):271-7
references: 12787789
references: J Neurosci. 2006 Sep 13;26(37):9434-8
references: 16971527
references: Psychopharmacology (Berl). 1992;106(3):321-9
references: 1570377
references: Nat Neurosci. 2006 Jun;9(6):732-4
references: 16715079
references: Neuroscience. 1996 Jul;73(1):217-31
references: 8783244
references: Therapie. 2005 Sep-Oct;60(5):441-60
references: 16433010
references: J Psychopharmacol. 2000 Jun;14(2):114-38
references: 10890307
references: J Biol Rhythms. 2005 Apr;20(2):122-31
references: 15834109
references: Pharmacol Biochem Behav. 1993 May;45(1):27-33
references: 8516369
references: Pharmacol Ther. 1995 Feb;65(2):241-63
references: 7792317
references: Brain Res. 1996 Mar 25;713(1-2):108-13
references: 8724981
references: Brain Res. 1998 Sep 28;806(2):257-70
references: 9739147
references: Brain Res. 1988 Oct 18;462(2):301-12
references: 3191391
references: Pharmacol Ther. 1996;71(3):253-312
references: 8940745
references: Neuropsychopharmacology. 2001 Dec;25(6):871-80
references: 11750180
references: Neuroscience. 1998 Jun;84(4):1059-73
references: 9578395
references: Prog Neurobiol. 2003 Jun;70(2):83-244
references: 12927745
references: J Neurosci. 1996 Dec 15;16(24):8208-20
references: 8987845
references: Pharmacol Ther. 2006 May;110(2):135-370
references: 16522330
references: Clin Endocrinol (Oxf). 2005 Sep;63(3):298-304
references: 16117817
references: J Neurochem. 1996 Feb;66(2):748-55
references: 8592148
references: Doc Ophthalmol. 2004 Jan;108(1):17-40
references: 15104164
references: Mol Microbiol. 1996 Jul;21(1):5-11
references: 8843429
references: Psychiatry Res. 1994 Aug;53(2):173-84
references: 7824677
references: Chronobiol Int. 2005;22(5):937-43
references: 16298778
references: Brain Res Rev. 2006 Jun;51(1):1-60
references: 16337005
references: Biol Psychiatry. 2005 Oct 15;58(8):658-67
references: 16271314
references: Int Clin Psychopharmacol. 2006 Feb;21 Suppl 1:S11-5
references: 16436934
references: Biol Psychiatry. 2006 Aug 1;60(3):275-81
references: 16458262
references: Brain Res. 2006 Apr 14;1083(1):96-102
references: 16551464
references: Harv Rev Psychiatry. 1999 Jul-Aug;7(2):69-84
references: 10471245
references: Neuroscience. 2006;137(1):287-99
references: 16289351
references: Eur J Neurosci. 2005 Nov;22(10):2531-40
references: 16307595
references: Ann Med. 1999 Feb;31(1):12-33
references: 10219711
references: Nature. 2002 May 16;417(6886):329-35
references: 12015613
references: Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4686-91
references: 11917109
references: Eur J Pharmacol. 2005 Dec 19;527(1-3):86-93
references: 16307740
references: J Clin Psychiatry. 1992 Jul;53(7):252-5
references: 1639745
references: J Neurosci Res. 2002 May 15;68(4):470-8
references: 11992474
references: Brain Res. 2001 Aug 3;909(1-2):81-91
references: 11478924
references: Genes Cells. 2002 May;7(5):447-59
references: 12047348
references: Am J Physiol. 1997 Apr;272(4 Pt 2):R1178-88
references: 9140018
references: Horm Behav. 2006 May;49(5):557-74
references: 16497305
references: J Clin Psychiatry. 1995 Sep;56(9):395-401
references: 7665537
references: J Chem Neuroanat. 2003 Jul;25(4):293-310
references: 12842274
references: Chronobiol Int. 2003 Mar;20(2):189-207
references: 12723880
references: Neurosci Lett. 2006 Jul 31;403(1-2):78-83
references: 16781060
references: J Biol Rhythms. 2001 Feb;16(1):19-24
references: 11220774
references: Brain Res Bull. 1992 Apr;28(4):629-31
references: 1617446
references: Neuroscience. 2003;119(2):567-76
references: 12770569
references: Psychoneuroendocrinology. 2005 Jun;30(5):438-52
references: 15721056
references: Biol Psychiatry. 2006 Oct 15;60(8):896-9
references: 16631132
references: Neuropsychopharmacology. 1995 Feb;12(1):17-37
references: 7766283
references: Brain Res. 2007 Jan 19;1129(1):34-42
references: 17156761
references: Brain Res. 2001 Mar 2;893(1-2):77-83
references: 11222995
references: Psychopharmacology (Berl). 2007 Mar;190(4):575-9
references: 17171557